Advancing pharmaceutical research through intelligent automation and collaborative innovation
The AIAgent4Science Consortium brings together leading research institutions, innovative startups, and world-class researchers to advance the application of AI agents in drug discovery and pharmaceutical research.
Our mission is to accelerate drug discovery through the development and deployment of autonomous AI agents that can design experiments, analyze data, and generate insights at unprecedented scales.
Human Chemical
Human Chemical
Kiin Bio
Kiin Bio
Coincidence Labs
Coincidence Labs
Happy Potato, Inc.
Onepot AI, Inc.
Onepot AI, Inc.
Plex Research
Convexia
Convexia
Kepler AI, Nome Bio
Zetta Venture Partners
Augmented Nature
Broad Institute of MIT and Harvard, University of Cambridge
Uppsala University
Broad Institute of MIT and Harvard, UCLA
Broad Institute of MIT and Harvard
Broad Institute of MIT and Harvard
University of Cambridge, Khalifa University, Babeş-Bolyai University
Uppsala University, Pixl Bio AB
Exploring the applications and case studies of autonomous AI agents in pharmaceutical research and development.
Developing intelligent systems that can design, execute, and analyze experiments without human intervention.
Leveraging large-scale data analysis and machine learning to identify novel therapeutic targets and compounds.
Interested in joining the consortium or learning more about our work?
seal@understanding.bio
ola.spjuth@uu.se